Portfolio company
RSPR Pharma AB
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops oral therapies for respiratory and cardiovascular diseases, targeting patients with uncontrolled asthma and rare conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Resistentia Pharmaceuticals AB
This company develops immunotherapeutic products for patients suffering from allergic asthma and inflammatory disorders.
Areteia Therapeutics
The company develops an oral medication for patients with eosinophilic asthma to reduce inflammation and manage their condition.
Respira
This biopharmaceutical company develops inhaled drug-device therapies for patients with cardiopulmonary diseases such as pulmonary hypertension and interstitial lung disease.
AQUILON PHARMACEUTICALS
The company develops inhaled medicines and nasal sprays for patients with asthma, chronic obstructive pulmonary disease and other respiratory conditions.
Cereno Scientific
This biotech company develops epigenetic therapies for patients with rare cardiovascular and pulmonary diseases.
PHVS
This company develops oral therapies to treat and prevent hereditary angioedema attacks for patients with rare diseases.
Kinaset Therapeutics
This biopharmaceutical company develops inhaled anti-inflammatory therapies to treat patients with severe asthma and other respiratory diseases.
Avalyn Pharma
The company develops inhaled medicines to treat patients with rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.